• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障破坏与肌萎缩侧索硬化症的疾病侵袭性无关。

Blood-Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis.

作者信息

Prell Tino, Vlad Benjamin, Gaur Nayana, Stubendorff Beatrice, Grosskreutz Julian

机构信息

Department of Geriatrics, Halle University Hospital, Jena, Germany.

Department of Neurology, Jena University Hospital, Jena, Germany.

出版信息

Front Neurosci. 2021 Oct 29;15:656456. doi: 10.3389/fnins.2021.656456. eCollection 2021.

DOI:10.3389/fnins.2021.656456
PMID:34776835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8586537/
Abstract

The pathogenesis of the fatal neurodegenerative condition amyotrophic lateral sclerosis (ALS) remains to be fully understood. Blood-brain barrier damage (BBBD) has been implicated as an exacerbating factor in several neurodegenerative conditions, including ALS. Therefore, this cross-sectional study used the novel D50 progression model to assess the clinical relevance of BBBD within a cohort of individuals with either ALS ( = 160) or ALS mimicking conditions ( = 31). Routine laboratory parameters in cerebrospinal fluid (CSF) and blood were measured, and the ratio of CSF to serum albumin levels (Qalb) was used as a proxy measure of BBBD. In the univariate analyses, Qalb levels correlated weakly with disease aggressiveness (as indicated by individual D50 values) and physical function (as measured by ALS Functional Rating Scale). However, after adjustment for cofactors in the elastic net regularization, only having limb-onset disease was associated with BBBD. The results reported here emphasize the clinical heterogeneity of ALS and the need for additional longitudinal and multi-modal studies to fully clarify the extent and effect of BBBD in ALS.

摘要

致命的神经退行性疾病肌萎缩侧索硬化症(ALS)的发病机制仍有待充分了解。血脑屏障损伤(BBBD)被认为是包括ALS在内的几种神经退行性疾病的一个加重因素。因此,这项横断面研究使用了新的D50进展模型,以评估在一组ALS患者(n = 160)或疑似ALS疾病患者(n = 31)中BBBD的临床相关性。测量了脑脊液(CSF)和血液中的常规实验室参数,并将CSF与血清白蛋白水平之比(Qalb)用作BBBD的替代指标。在单变量分析中,Qalb水平与疾病侵袭性(由个体D50值表示)和身体功能(由ALS功能评定量表测量)弱相关。然而,在弹性网络正则化中对协变量进行调整后,只有肢体起病的疾病与BBBD相关。此处报告的结果强调了ALS的临床异质性,以及需要进行更多的纵向和多模式研究,以充分阐明BBBD在ALS中的程度和影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df23/8586537/5d4597c7f4d4/fnins-15-656456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df23/8586537/5d4597c7f4d4/fnins-15-656456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df23/8586537/5d4597c7f4d4/fnins-15-656456-g001.jpg

相似文献

1
Blood-Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis.血脑屏障破坏与肌萎缩侧索硬化症的疾病侵袭性无关。
Front Neurosci. 2021 Oct 29;15:656456. doi: 10.3389/fnins.2021.656456. eCollection 2021.
2
Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model.脑脊液神经丝轻链(NfL)可预测肌萎缩侧索硬化症的疾病侵袭性:D50疾病进展模型的应用
Front Neurosci. 2021 Apr 6;15:651651. doi: 10.3389/fnins.2021.651651. eCollection 2021.
3
Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients.脑脊液同型半胱氨酸水平升高与肌萎缩侧索硬化症患者的血脑屏障破坏有关。
Neurol Sci. 2020 Jul;41(7):1865-1872. doi: 10.1007/s10072-020-04292-x. Epub 2020 Feb 21.
4
Associations of cerebrospinal fluid profiles with severity and mortality risk of amyotrophic lateral sclerosis.脑脊液特征与肌萎缩侧索硬化症严重程度及死亡风险的关联。
Front Neurosci. 2024 May 15;18:1375892. doi: 10.3389/fnins.2024.1375892. eCollection 2024.
5
Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis.将 D50 疾病进展模型应用于肌萎缩侧索硬化症的灰、白质病理学。
Neuroimage Clin. 2020;25:102094. doi: 10.1016/j.nicl.2019.102094. Epub 2019 Nov 28.
6
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients.中枢神经系统屏障损伤在肌萎缩侧索硬化症中的意义:患者的性别差异。
Int J Mol Sci. 2023 Jul 7;24(13):11196. doi: 10.3390/ijms241311196.
7
Choroid plexus enlargement in amyotrophic lateral sclerosis patients and its correlation with clinical disability and blood-CSF barrier permeability.肌萎缩侧索硬化症患者脉络丛增大及其与临床残疾和血脑屏障通透性的相关性。
Fluids Barriers CNS. 2024 Apr 17;21(1):36. doi: 10.1186/s12987-024-00536-6.
8
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis.脑脊液蛋白和白蛋白升高预示着脊髓肌萎缩预后不良。
Int J Mol Sci. 2022 Sep 21;23(19):11063. doi: 10.3390/ijms231911063.
9
Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中胱抑素C水平的测定。
Int J Clin Exp Pathol. 2015 May 1;8(5):5419-26. eCollection 2015.
10
Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.肌萎缩侧索硬化症患者脑脊液中铁蛋白水平升高。
Acta Neurol Scand. 2017 Aug;136(2):145-150. doi: 10.1111/ane.12708. Epub 2016 Nov 1.

引用本文的文献

1
Restoring brain barriers: an innovative approach for treating neurological disorders.恢复脑屏障:一种治疗神经系统疾病的创新方法。
Fluids Barriers CNS. 2025 Jul 10;22(1):72. doi: 10.1186/s12987-025-00688-z.
2
Does Lumbar Puncture Still Have Clinical Value for Patients with Amyotrophic Lateral Sclerosis?腰椎穿刺对肌萎缩侧索硬化症患者仍具有临床价值吗?
Brain Sci. 2025 Feb 27;15(3):258. doi: 10.3390/brainsci15030258.
3
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach.肌萎缩侧索硬化症生物标志物的研究进展:病理生理学方法。

本文引用的文献

1
Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data.肌萎缩侧索硬化症疾病进程建模:来自横断面健康相关生活质量数据的伪纵向见解。
Health Qual Life Outcomes. 2020 May 1;18(1):117. doi: 10.1186/s12955-020-01372-6.
2
Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.疾病进展会影响肌萎缩侧索硬化症患者的健康相关生活质量。
J Neurol Sci. 2019 Feb 15;397:92-95. doi: 10.1016/j.jns.2018.12.035. Epub 2018 Dec 28.
3
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.
Int J Mol Sci. 2024 Oct 10;25(20):10900. doi: 10.3390/ijms252010900.
4
C9ORF72 patient-derived endothelial cells drive blood-brain barrier disruption and contribute to neurotoxicity.C9ORF72 患者来源的内皮细胞驱动血脑屏障破坏并导致神经毒性。
Fluids Barriers CNS. 2024 Apr 11;21(1):34. doi: 10.1186/s12987-024-00528-6.
5
The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders.CD8+T 细胞在衰老和神经退行性疾病中的作用。
Front Immunol. 2023 Jul 28;14:1233870. doi: 10.3389/fimmu.2023.1233870. eCollection 2023.
6
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients.中枢神经系统屏障损伤在肌萎缩侧索硬化症中的意义:患者的性别差异。
Int J Mol Sci. 2023 Jul 7;24(13):11196. doi: 10.3390/ijms241311196.
7
Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients.脑脊髓液/血清白蛋白比值与肌萎缩侧索硬化症表型的关系:328 例患者的回顾性研究。
Neurol Sci. 2023 May;44(5):1679-1685. doi: 10.1007/s10072-023-06604-3. Epub 2023 Jan 17.
8
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis.脑脊液蛋白和白蛋白升高预示着脊髓肌萎缩预后不良。
Int J Mol Sci. 2022 Sep 21;23(19):11063. doi: 10.3390/ijms231911063.
9
The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化中神经元易损性和恢复力的细胞自主和非细胞自主方面
Biology (Basel). 2022 Aug 8;11(8):1191. doi: 10.3390/biology11081191.
10
Taking Advantages of Blood-Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?利用血脑屏障或脊髓屏障的改变,或恢复这些屏障以优化肌萎缩侧索硬化症的治疗?
J Pers Med. 2022 Jun 29;12(7):1071. doi: 10.3390/jpm12071071.
阿尔茨海默病和其他神经退行性疾病中的血脑屏障破坏。
Nat Rev Neurol. 2018 Mar;14(3):133-150. doi: 10.1038/nrneurol.2017.188. Epub 2018 Jan 29.
4
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.阿尔茨海默病中的脑血流调节与神经血管功能障碍
Nat Rev Neurosci. 2017 Jul;18(7):419-434. doi: 10.1038/nrn.2017.48. Epub 2017 May 18.
5
Factors predicting survival in ALS: a multicenter Italian study.肌萎缩侧索硬化症患者生存的预测因素:一项意大利多中心研究。
J Neurol. 2017 Jan;264(1):54-63. doi: 10.1007/s00415-016-8313-y. Epub 2016 Oct 24.
6
Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis.散发性肌萎缩侧索硬化症中血脊髓屏障的改变
Neuropathology. 2015 Dec;35(6):518-28. doi: 10.1111/neup.12221. Epub 2015 Aug 4.
7
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的血-脊髓屏障破坏和周细胞减少。
Acta Neuropathol. 2013 Jan;125(1):111-20. doi: 10.1007/s00401-012-1039-8. Epub 2012 Sep 1.
8
Impaired blood-brain/spinal cord barrier in ALS patients.肌萎缩侧索硬化症患者的血脑/脊髓屏障受损。
Brain Res. 2012 Aug 21;1469:114-28. doi: 10.1016/j.brainres.2012.05.056. Epub 2012 Jun 27.
9
Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.铁在大脑皮质深层的沉积导致 ALS 的 MRI 信号异常:7 特斯拉 MRI 与病理学的相关性。
PLoS One. 2012;7(4):e35241. doi: 10.1371/journal.pone.0035241. Epub 2012 Apr 17.
10
The blood-spinal cord barrier: morphology and clinical implications.血-脊髓屏障:形态学及临床意义。
Ann Neurol. 2011 Aug;70(2):194-206. doi: 10.1002/ana.22421. Epub 2011 Jun 14.